PLANTATION, FL, Dec 15, 2021 /PRNewswire/ - Akumin Inc. (NASDAQ: AKU) (TSX: AKU) ("Akumin" or the "Company") is pleased to announce today its full-year 2022 financial guidance, following the previously announced closing of the Alliance Healthcare Services, Inc. ("Alliance") acquisition. The Alliance acquisition closed on September 1, 2021, and Consolidated Financial Results for the quarter ended September 30th, 2021, which includes only one month of Alliance results, were released on December 13th, 2021.
Akumin currently expects that the financial results of the combined company for 2022 will be as follows:
Summary Consolidated Financial Results (in thousands, except for per share amounts)
| | Akumin Full-Year 2022 Guidance |
| Revenue | $760-780mm |
| Adjusted EBITDA (1) | $155-170mm |
| Capex (2) | $85mm |
| |
| (1) See "Non-IFRS Measures" below. |
| (2) Capex includes $59mm of growth Capex vs $26mm maintenance capex.. |
Akumin is also pleased to announce that it has filed its corporate presentation for the combined enterprise, and it is now available on the company's website https://akumin.com/investor-relations/reports/. The Company looks forward to discussing the merits of the new Akumin platform, and its future outlook, on the upcoming investor call, details of which are below.
Unless otherwise indicated, all amounts are expressed in U.S. dollars. Certain metrics are non-GAAP measures. See "Non-GAAP Measures" of this press release for further details. The Company's consolidated financial statements for Q3 Fiscal 2021 and related management's discussion and analysis are available in Akumin's public disclosure at www.sedar.com and www.sec.gov.
Investor Presentation
Akumin would like to invite interested parties to an investor presentation to be held on Friday, December 17, 2021 from 8:00 a.m. to 9:00 a.m. Eastern Time where management will discuss changes to the Company's business resulting from the closing of the Alliance HealthCare Services acquisition, as well as Q3 Fiscal 2021 results. To access the conference call, dial toll-free in the U.S. or Canada 888-394-8218 or, for international callers, 647-484-0475. A related presentation will be available from Akumin's public disclosure at www.sedar.com or www.sec.gov and also from Akumin's website (www.akumin.com) and at https://akum.in/InvestorPresentation. Participants are asked to connect at least 10 minutes prior to the beginning of the call to ensure participation. The webcast archive will be available for 90 days. A replay of the presentation will also be available until Friday, December 24, 2021 by calling 647-436-0148 or toll-free 1-888-203-1112, using passcode number 6766278.
About Akumin
Akumin is a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service line needs. With the acquisition of Alliance HealthCare Services, Akumin now provides (1) fixed-site outpatient diagnostic imaging services through a network of more than 200 owned and/or operated imaging locations; and (2) outpatient radiology and oncology services and solutions to approximately 1,000 hospitals and health systems across 46 states. By combining clinical and operational expertise with the latest advances in technology and information systems, Akumin and its ~4,000 Team Members facilitate more efficient and effective diagnosis and treatment for patients and their providers in 46 states. Akumin's imaging procedures include MRI, CT, positron emission tomography (PET and PET/CT), ultrasound, diagnostic radiology (X-ray), mammography, and other interventional procedures; our cancer care services include a full suite of radiation therapy and related offerings. For more information, visit www.akumin.com and www.alliancehealthcareservices-us.com.